The effect of dietary salt restriction on hypertension in peritoneal dialysis patients

To investigate the effect of dietary salt restriction on blood pressure levels, total sodium removal, and hydration status of peritoneal dialysis (PD) patients. Materials and methods: Thirty-one stable PD patients who consulted a renal dietitian monthly for dietary recommendations, including restricted salt intake 0.05) for the whole sample, and from 164.3 ± 70.9 to 154.2 ± 72.3 mmol/day (P > 0.05) for the hypertensive subgroup (n: 17). Systolic blood pressure (from 134.3 ± 20.1 to 127.2 ± 19.5 mmHg, P: 0.01), diastolic blood pressure (from 83.2 ± 12.0 to 77.4 ± 10.5 mmHg, P: 0.01) and total body water (from 39.2 ± 10.9 to 38.3 ± 9.3 L, P: 0.04) decreased significantly. Conclusion: We demonstrated that even a little reduction in daily dietary sodium intake caused significant decreases in blood pressure levels and fluid overload.

The effect of dietary salt restriction on hypertension in peritoneal dialysis patients

To investigate the effect of dietary salt restriction on blood pressure levels, total sodium removal, and hydration status of peritoneal dialysis (PD) patients. Materials and methods: Thirty-one stable PD patients who consulted a renal dietitian monthly for dietary recommendations, including restricted salt intake 0.05) for the whole sample, and from 164.3 ± 70.9 to 154.2 ± 72.3 mmol/day (P > 0.05) for the hypertensive subgroup (n: 17). Systolic blood pressure (from 134.3 ± 20.1 to 127.2 ± 19.5 mmHg, P: 0.01), diastolic blood pressure (from 83.2 ± 12.0 to 77.4 ± 10.5 mmHg, P: 0.01) and total body water (from 39.2 ± 10.9 to 38.3 ± 9.3 L, P: 0.04) decreased significantly. Conclusion: We demonstrated that even a little reduction in daily dietary sodium intake caused significant decreases in blood pressure levels and fluid overload.

___

  • Brunkhorst R. Hypervolemia, arterial hypertension and cardiovascular disease: a largely neglected problem in peritoneal dialysis. Clin Nephrol 2008; 69: 233–238.
  • Collins AJ, Hao W, Xia H, Ebben JP, Everson SE, Constantini EG, Ma JZ. Mortality risks of peritoneal dialysis and hemodialysis. Am J Kidney Dis 1999; 34: 1065–1074. 3. Longenecker JC, Coresh J, Powe NR, Levey AS, Fink NE, Martin A, Klag MJ. Traditional cardiovascular disease risk factors in dialysis patients compared with the general population: the
  • CHOICE Study. J Am Soc Nephrol 2002; 13: 1918–1927.
  • Saldanha LF, Weiler EW, Gonick HC. Effect of continuous ambulatory peritoneal dialysis on blood pressure control. Am J Kidney Dis 1993; 21: 184–188.
  • Cocchi R, Degli Esposti E, Fabbri A, Lucatello A, Sturani A, Quarello F, Boero R, Bruno M, Dadone C, Favazza A et al. Prevalence of hypertension in patients on peritoneal dialysis: results of an Italian multicentre study. Nephrol Dial Transplant 1999; 14: 1536–1540.
  • Gunal AI, Duman S, Ozkahya M, Toz H, Asci G, Akcicek F, Basci A. Strict volume control normalizes hypertension in peritoneal dialysis patients. Am J Kidney Dis 2001; 37: 588– 593.
  • Ateş K,  Nergizoğlu G,  Keven K,  Sen A,  Kutlay S,  Ertürk S, Duman N, Karatan O, Ertuğ AE. Effect of fluid and sodium removal on mortality in peritoneal dialysis patients. Kidney Int 200; 60: 767–776.
  • Van Biesen W, Vanholder R, Veys N, Lameire N. Improving salt balance in peritoneal dialysis patients. Perit Dial Int 2005; 25: 73–75.
  • Kooman J, Basci A, Pizzarelli F, Canaud B, Haage P, Fouque D, Konner K, Martin-Malo A, Pedrini L, Tattersall J et al. EBPG guideline on nutrition. Nephrol Dial Transplant 2007; 22: 45– 87.
  • Whitworth JA. 2003 World Health Organization (WHO)/ International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens 2003; 21: 1983– 1992.
  • Koc M, Toprak A, Tezcan H, Bihorac A, Akoglu E, Ozener IC. Uncontrolled hypertension due to volume overload contributes to higher left ventricular mass index in CAPD patients. Nephrol Dial Transplant 2002; 17: 1661–1666.
  • Erek E, Süleymanlar G, Serdengeçti K, Altıparmak MR, Sifil A, Seyahi N. Registry of nephrology, dialysis and transplantation in Turkey. Turkish Society of Nephrology, 2007.
  • D’Amico M, Locatelli F. Hypertension in dialysis: pathophysiology and treatment. J Nephrol 2002; 15: 438–445.
  • Fagugli RM, Pasini P, Quintaliani G, Pasticci F, Ciao G, Cicconi B, Ricciardi D, Santirosi PV, Buoncristiani E, Timio F et al. Association between extracellular water, left ventricular mass and hypertension in haemodialysis patients. Nephrol Dial Transplant 2003; 18: 2332–2338.
  • Khandelwal M, Kothari J, Krishnan M, Liakopoulos V, Tziviskou E, Sahu K, Chatalalsingh C, Bargman J, Oreopoulos D. Volume expansion and sodium balance in peritoneal dialysis patients. Part II: Newer insights in management. Adv Perit Dial 2003; 19: 44–52.
  • Fourtounas C, Hardalias A, Dousdampanis P, Papachristopoulos B, Savidaki E, Vlachojannis JG. Sodium removal in peritoneal dialysis: the role of icodextrin and peritoneal dialysis modalities. Adv Perit Dial 2008; 24: 27–31.
  • Chen W, Cheng LT, Wang T. Salt and fluid intake in the development of hypertension in peritoneal dialysis patients. Ren Fail 2007; 29: 427–432.
  • Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3–10.
  • Erdem Y, Arici M, Altun B, Turgan C, Sindel S, Erbay B, Derici U, Karatan O, Hasanoglu E, Caglar S. The relationship between hypertension and salt intake in Turkish population: SALTURK study. Blood Press 2010; 19: 313–318.
  • Kutlugün AA, Arıcı M, Yıldırım T, Turgut D, Yılmaz R, Altındal M,  Altun B,  Erdem Y,  Yasavul U,  Turgan C. Daily sodium intake in chronic kidney disease patients during nephrology clinic follow-up: an observational study with 24-hour urine sodium measurement. Nephron Clin Pract 2011; 118: 361–366.
  • Dong J, Li Y, Yang Z, Luo J. Low dietary sodium intake increases the death risk in peritoneal dialysis. Clin J Am Soc Nephrol 2010; 5: 240–247.
Turkish Journal of Medical Sciences-Cover
  • ISSN: 1300-0144
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Effects of ozone therapy and taurine on ischemia/reperfusion-induced testicular injury in a rat testicular torsion model

Tolga Reşat AYDOS, Mehmet Murad BAŞAR, Oğuz KUL, Hasan Tarık ATMACA

Comparative study of photodynamic therapy monotherapy versus triple management in age-related macular degeneration

Ahmet SELİM, Nilüfer KOÇAK, Hüseyin ASLANKARA, Süleyman KAYNAK

Does lymph node involvement affect the patterns of recurrence in stage IB cervical cancer?

Işın ÜREYEN, Ülkü AKSOY, Betül DÜNDAR, Ömer Lütfi TAPISIZ, Mustafa Alper KARALÖK, Ahmet Taner TURAN, Nurettin BORAN, Hakkı Gökhan TULUNAY

Association between the apelin rs2235306 gene polymorphism and metabolic syndrome

Mohammad HASHEMI, Hamzeh REZAEI, Ebrahim ESKANDARI-NASAB

Review of clinical experience with acute cholecystitis on the development of subsequent gallstone--elated complications

Mustafa HASBAHÇECİ, Orhan ALİMOĞLU, Fatih BAŞAK, Tolga CANBAK, Abdullah ŞİŞİK

Evaluation and comparison of alpha- and beta-amanitin toxicity on MCF-7 cell line

Ertuğrul KAYA, Recep BAYRAM, Kürşat Oğuz YAYKAŞLI, İsmail YILMAZ, Sait BAYRAM

The relation between Helicobacter pylori and ulcerative colitis

Sedat CANER, Akif ALTINBAŞ, Yusuf YEŞİL, Yavuz BEYAZIT, Barış YILMAZ, Osman YÜKSEL

The correlation of ECHO findings of right cardiac pathologies with BNP, uric acid, and CRP in OSAS

Ömer ARAZ, Elif YILMAZEL UÇAR, Hüsnü DEĞİRMENCİ, Didem PULUR

Surgery for intractable temporal lobe epilepsy: experience of a single institution

Gökhan KURT, Mehmet TÖNGE, Emrah ÇELTİKÇİ, Irem ÇAPRAZ, Ayşe SERDAROĞLU, Erhan BİLİR

Comparative study of photodynamic therapy monotherapy versus triple management in age-related macular degeneration*

Hüseyin ASLANKARA, Ahmet SELİM, Süleyman KAYNAK, Nilüfer KOÇAK